News Releases
Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.
-
Nov 25, 2019Approval based on Asian PREVAIL study of men with metastatic castration-resistant prostate cancer
-
Oct 31, 2019- Results were published online and in the October 31 print edition of the Journal -
-
Oct 28, 2019- Four innovators awarded $200,000 in total grants and resources following live pitch event to a panel of judges that included celebrity entrepreneur Bill Rancic -
-
Oct 25, 2019Approval follows accelerated assessment, orphan designation by European Medicines Agency
-
Oct 1, 2019Astellas Commits Nearly $13 Million to Fund Boston-Area Start-Up Innovation in Cell and Gene TherapyFinancial Support for LabCentral Incubators Builds on Astellas' $1 Billion+ Investment in Boston's Life Science Community
-
Sep 30, 2019- Finalists will present their ideas during a live pitch event
-
Sep 28, 2019- Study Met Outcomes for Safety and 71 Percent of Patients with Locally Advanced or Metastatic Urothelial (Bladder) Cancer Had a Confirmed Response -
-
Sep 24, 2019- Astellas named Working Mother "100 Best Company" for fifth consecutive year -